Objective-Perivascular adipose tissue (PVAT) expands during obesity, is highly inflamed, and correlates with coronary plaque burden and increased cardiovascular risk. We tested the hypothesis that PVAT contributes to the vascular response to wire injury and investigated the underlying mechanisms. Approach and Results-We transplanted thoracic aortic PVAT from donor mice fed a high-fat diet to the carotid arteries of recipient high-fat diet-fed low-density lipoprotein receptor knockout mice. Two weeks after transplantation, wire injury was performed, and animals were euthanized 2 weeks later. Immunohistochemistry was performed to quantify adventitial macrophage infiltration and neovascularization and neointimal lesion composition and size. Transplanted PVAT accelerated neointimal hyperplasia, adventitial macrophage infiltration, and adventitial angiogenesis. The majority of neointimal cells in PVAT-transplanted animals expressed α-smooth muscle actin, consistent with smooth muscle phenotype. Deletion of monocyte chemoattractant protein-1 in PVAT substantially attenuated the effects of fat transplantation on neointimal hyperplasia and adventitial angiogenesis, but not adventitial macrophage infiltration. Conditioned medium from perivascular adipocytes induced potent monocyte chemotaxis in vitro and angiogenic responses in cultured endothelial cells.
O besity is associated with expansion of metabolically active adipose tissues leading to local and systemic inflammation, insulin resistance, and dyslipidemia, all of which can contribute to cardiovascular disease. 1 In addition to these systemic effects, obesity is associated with expansion of perivascular adipose tissue (PVAT) immediately adjacent to the adventitia of large arteries. Emerging evidence suggests that PVAT may contribute to the pathogenesis of vascular disease. 2 PVAT is anatomically colocalized with atherosclerotic lesions in humans, correlating with plaque burden and vascular calcification. 3, 4 Also, inflammatory cell infiltration was reported to be markedly increased in PVAT surrounding atherosclerotic human aorta as compared with nondiseased aorta. 5 Moreover, inflammatory gene expression was shown to be upregulated, 5, 6 and expression of adiponectin, an anti-inflammatory adipokine, was downregulated, 7, 8 in PVAT surrounding diseased human coronary arteries. Thus, both the amount of PVAT and the degree of PVAT inflammation correlate with cardiovascular disease in humans.
Inflammation of human PVAT may in part relate to the unique properties of human perivascular adipocytes, which express higher levels of chemokines compared with adipocytes from other depots. In particular, expression of monocyte chemoattractant protein-1 (MCP-1) is ≈10to 40-fold higher in perivascular adipocytes (coronary artery) compared with corresponding subcutaneous and perirenal adipocytes derived from the same subjects. 9 Likewise, human perivascular adipocytes surrounding the radial artery secrete more MCP-1 than visceral or subcutaneous adipocytes derived from the same patients. 10 MCP-1 is best known for its role in recruiting monocytes/macrophages to the arterial wall, but it may also contribute to vascular smooth muscle cell (VSMC) proliferation, angiogenesis, and other pathological processes. [11] [12] [13] [14] [15] In this regard, MCP-1 has been implicated in both atherosclerosis and wire injury-induced neointimal hyperplasia in rodent models. [11] [12] [13] [14] [15] However, the specific role of MCP-1 expression in PVAT in local vascular pathology has never been examined.
To examine the influence of PVAT on vascular disease, rodent models have been devised, each of which has inherent strengths and limitations. Several mouse models spontaneously lack PVAT, including the A-ZIP/F-1 mouse, the FAT-ATTAC mouse, and the SMPG knockout mouse. [16] [17] [18] Among these models, only the SMPG knockout mouse (generated by breeding peroxisome proliferator-activated receptor-γ-floxed mice with SM22α-Cre mice) is selectively devoid of PVAT rather than generally lipodystrophic; however, loss of peroxisome proliferator-activated receptor-γ expression in smooth muscle cells in the SMPG knockout mouse may complicate the vascular phenotype. 18 Surgical models have also been developed which involve removal of endogenous PVAT and transplantation of adipose tissue to the arterial wall. [19] [20] [21] Surgically removing endogenous PVAT is technically demanding and potentially can induce arterial injury. Likewise, transplanting PVAT poses major technical challenges given the minute size of this adipose depot in mice. In fact, prior publications have not included data on transplanted PVAT [19] [20] [21] ; rather, the investigators transplanted subcutaneous or epididymal fat, which differs phenotypically from PVAT, to the vascular wall.
In this study, we devised a novel model enabling us to transplant PVAT harvested from the aorta to a region of the arterial tree of mice that is normally devoid of PVAT, the common carotid artery. We found that transplanted PVAT augmented injury-induced neointimal hyperplasia in the setting of highfat diet (HFD), whereas subcutaneous adipose tissue (SQAT) had no effect. The effects of PVAT transplantation were at least in part dependent on MCP-1 released locally by the adipose tissue. These findings demonstrate a causal relationship between PVAT and the development of local vasculopathy and implicate MCP-1 secretion by PVAT as a mediator of this pathological process.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results
To study the local effect of transplanted adipose tissue in vivo, PVAT was collected from the thoracic aorta of donor C57Bl/6J (wild type [wt]) male animals fed an HFD for 2 weeks. Inguinal SQAT was harvested from the same group of donor mice and used as a control. PVAT from donor MCP-1 −/− male mice on a C57Bl/6J background fed an HFD was also harvested for a second treatment group. We transplanted 2 to 3 mg of PVAT (wt or MCP-1 −/− ) or SQAT (wt) per mouse and executed wire injury of the left common carotid arteries of HFD-fed low-density lipoprotein receptor knockout mice 14 days after transplantation. [22] [23] [24] [25] To control for surgical manipulations, sham transplantation was performed on the contralateral right common carotid arteries and the left common carotid arteries of separate mice.
At the time of wire injury, sham-transplanted segments were devoid of fat and showed no evidence of fibrosis or adhesions ( Figure 1A and 1B), whereas PVAT-( Figure 1C and 1D) and SQAT-(not shown) transplanted segments demonstrated glistening fat that was incorporated into the carotid adventitia and exhibited grossly visible neovessels. Histology of PVAT-transplanted arteries demonstrated a mixed population of white and brown adipocytes abutting the adventitia, with inflammatory cells dispersed throughout the adipose tissue ( Figure 2 ). Assessment of gene expression demonstrated that in transplanted PVAT and SQAT, mRNA expression of adiponectin and leptin was similar to endogenous fat harvested from the corresponding depots of recipient mice, suggesting that adipose phenotype was unaffected by the transplantation procedure ( Figure II in the online-only Data Supplement). Comparing PVAT-transplanted animals with sham-transplanted animals, total cholesterol (1085±187 versus 1368±457 mg/dL, respectively; P=0.38) and triglyceride levels (440±175 versus 484±134 mg/dL, respectively; P=0.75) were unchanged. These findings indicate that the transplanted adipose tissue acquired sufficient nutritive blood flow within 2 weeks to maintain viability and that the phenotype of adipose tissue and systemic lipid levels were not significantly affected by the transplantation procedure.
Fourteen days after wire injury, the mice were euthanized, carotid arteries were harvested, and neointimal formation was examined in PVAT-transplanted versus sham-transplanted and SQAT-transplanted arteries. Histological analysis demonstrated that, compared with sham controls (Figure 2A ), transplanted PVAT caused an increase in injury-induced neointimal area in low-density lipoprotein receptor knockout mice in the setting of HFD (neointimal formation, Figure 2B ). In contrast, transplanted PVAT from MCP-1 −/− mice failed to induce a robust neointimal formation ( Figure 2C ). Quantification analysis revealed that, at 14 days after injury, wt PVAT resulted in ≈3-fold increase in neointimal formation compared with sham transplant control ( Figure 2D , Figure III in the online-only Data Supplement). Transplanted SQAT was not statistically different in influencing neointimal hyperplasia compared with sham transplantation. Taken together, these data suggest that transplanted PVAT augments neointimal hyperplasia through a mechanism that is dependent on locally produced MCP-1.
To determine the composition of the neointimal formation in PVAT-transplanted mice, we performed immunostaining for α-smooth muscle actin ( Figure 3 ). We found that compared with sham-transplanted controls ( Figure 3A ), mice transplanted with wt PVAT exhibited a smooth muscle actinrich neointimal formation, suggesting a predominant VSMC composition of the neointima ( Figure 3B and Figure IV in the online-only Data Supplement). We also detected rare cells expressing the macrophage marker F4/80 dispersed throughout the neointima ( Figure 4B In view of previous reports that HFD induces inflammation of adipose tissues, especially visceral adipose tissues, we surmised that inflammatory cell infiltration in the adjacent vascular adventitia would be enhanced in PVAT-transplanted arteries subjected to wire injury. Indeed, staining for F4/80 demonstrated increased infiltration of macrophages into In contrast, transplanted wild-type (wt) PVAT markedly increased the presence of adventitial macrophages surrounding injured arteries (B, red arrows); transplanted monocyte chemoattractant protein-1-deficient (MCP-1 −/− ) PVAT was associated with a similar increase in the infiltration of adventitial macrophages (C, red arrows). In all panels, the blue line demarcates the external elastic lamina of the injured vessel; black arrow in B points to neointimal F4/80 staining. Scale bar=50 μm. Quantification of adventitial macrophages in all 3 groups is shown in D: sham transplant, 81±12 cells/mm 2 ; MCP-1 −/− PVAT, 174±48 cells/mm 2 ; wt PVAT, 220±108 cells/mm 2 (all data expressed as mean±SD). *P<0.01 vs sham transplant. E, mRNA levels of inflammatory cytokines tumor necrosis factor-α (TNF-α), MCP-1, and macrophage inflammatory protein-1α (MIP-1α) in intact perivascular adipose tissue of C57Bl/6J mice fed a chow or high-fat diet (HFD) for 2 weeks. mRNA levels of selected genes were quantified by quantitative reverse transcription polymerase chain reaction after normalizing to the house-keeping gene RPLPO (ribosomal protein large O) according to previously described methods. 9 Results are normalized to the expression in chow-fed animals (red line). *P<0.001 vs chow from 3 independent experiments. Data in D and E were evaluated by 1-way ANOVA followed by Student-Newman-Keuls testing. F, Monocyte migration through endothelial monolayer toward conditioned medium from cultured subcutaneous (SQ) or perivascular (PV) murine adipocytes. Monocytes were stained with DAPI (4',6-diamidino-2-phenylindole), captured in 3 random view fields (×40), and quantified using ImageJ. *P<0.001 vs SQ. Data were compared by 1-way ANOVA followed by a 2-tailed Student t test to evaluate levels of significance at 95% confidence interval. this notion, we observed that, in addition to MCP-1, mRNA expression of tumor necrosis factor-α and macrophage inflammatory protein-1α in PVAT was ≈6-fold increased after 2 weeks of HFD versus chow diet ( Figure 4E ). Likewise, immunostaining for CD3 appeared similar in arteries transplanted with MCP-1 −/− PVAT as compared with wt PVAT, suggesting that MCP-1 gene deletion did not significantly impact T-cell recruitment ( Figure VI in the online-only Data Supplement).
Tissue macrophages can be classified by their polarization state, broadly described as proinflammatory (M1 polarized) versus anti-inflammatory (M2 polarized). We performed limited experiments to examine the mRNA expression of inducible nitric oxide synthase, a prototypical marker of M1 polarization, and Ym1, a marker of M2 polarization. Expression of inducible nitric oxide synthase was decreased by 6-fold (P<0.01) in MCP-1 −/− PVAT compared with wt PVAT, whereas the expression Ym1 was largely unchanged (P=NS). Interestingly, both of these markers were significantly downregulated in SQAT from the same animals, suggesting a depot-specific effect of MCP-1 gene deletion ( Figure  VII in the online-only Data Supplement).
We previously demonstrated that human perivascular adipocytes secrete considerably more MCP-1, interleukin-6, and interleukin-8 as compared with subcutaneous and perirenal adipocytes, 9 implying an enhanced chemoattractant property of perivascular adipocytes. To investigate the potential involvement of murine perivascular adipocytes in recruiting inflammatory cells, we analyzed the effects of conditioned medium from perivascular versus subcutaneous adipocytes on monocyte migration through an endothelial monolayer. Conditioned medium from murine perivascular adipocytes elicited a significantly greater monocyte migration compared with conditioned medium from subcutaneous adipocytes ( Figure 4F ). In a separate series of experiments, we conditioned medium for 4 hours at 37°C by incubating with 10 mg of intact, freshly harvested PVAT from either MCP-1 −/− or wt mice fed a Western diet for 4 weeks. We found that MCP-1 deletion did not diminish monocyte migration using the same in vitro assay ( Figure VIII in the online-only Data Supplement). Taken together, these results suggest that perivascular adipocytes are more potent than subcutaneous adipocytes at eliciting monocyte chemotaxis and that production of other chemokines in PVAT compensates for loss of MCP-1 to promote leukocyte recruitment.
The grossly visible blood vessels coursing through PVAT ( Figure 1 ) suggested enhanced neovascularization induced by the transplanted fat. This was confirmed by staining for the endothelial marker factor VIIIa-related antigen, which showed markedly increased adventitial neovessel formation after PVAT transplantation as compared with sham transplantation ( Figure 5B, red arrows) . Specifically, injured shamtransplanted adventitia was characterized by small vascular structures with poorly defined lumens, whereas PVAT transplantation was associated with an extensive adventitial vasculature between the transplanted PVAT and external elastic lamina of the artery. Interestingly, transplanted PVAT from MCP-1 −/− mice failed to elicit a robust angiogenic response in the adventitia, and the change in neovessel density was not statistically significant compared with sham transplantation ( Figure 5C ).
Adipocytes are powerful inducers of angiogenesis. 28 To compare the angiogenic potential of perivascular adipocytes with subcutaneous and visceral adipocytes, we performed an in vitro bioassay. Human perivascular preadipocytes were differentiated into mature adipocytes, as described previously, 9 and conditioned medium from the cultured cells was collected and applied to quiescent, subconfluent human coronary artery endothelial cell. Medium from identically processed subcutaneous and perirenal adipocytes derived from the same subjects was used for comparison purposes. We found that conditioned medium from differentiated cultures of human perivascular adipocytes strongly induced human coronary artery endothelial cell to elongate and form branching structures indicative of angiogenesis ( Figure 6 ). The angiogenic effects of conditioned medium from perivascular adipocytes far exceeded those elicited by subcutaneous or perirenal adipocytes.
Vascular endothelial growth factor (VEGF) is a powerful angiogenic factor that has been implicated in adventitial neovascularization after endothelial injury 29, 30 and is produced by adipocytes. 31 Therefore, we examined release of VEGF into the medium by perivascular adipocytes. As compared with subcutaneous adipocytes, perivascular adipocytes released approximately twice as much VEGF into the medium during incubation (94±35 versus 49±5 pg) for an equal number of cells. Figure 5 . Adventitial neovascularization of injured carotid arteries. Endothelial cells were identified by staining for the factor VIIIa-associated antigen. Wire injury after sham perivascular adipose tissue (PVAT) transplantation was associated with little evidence of adventitial neovessels (A). In sharp contrast, PVAT transplantation resulted in robust adventitial neovessels with well-defined lumens adjacent to the injured vessel (B, red arrows). In A and B, the blue line demarcates the external elastic lamina of the injured vessel. PVAT transplantation significantly increased the density of neovessels within 150 μm of the internal elastic lamina of injured carotid arteries from 30±8 to 100±50 vessels/mm 2 (C, n=4; *P<0.01 vs sham transplant, all data expressed as mean±SD). monocyte chemoattractant protein-1-deficient (MCP-1 −/− ) PVAT was not associated with a statistically significant increase in adventitial neovessel density (50±20 vessels/mm 2 ). Data were compared by 1-way ANOVA followed by a 2-tailed Student t test to evaluate levels of significance at 95% confidence interval.
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Discussion
PVAT, the adipose tissue surrounding the great vessels, expands during obesity, is highly inflamed, and correlates with coronary plaque burden and increased cardiovascular risk in humans. A consensus is emerging that PVAT is a cause of cardiovascular disease, but direct proof is lacking. 2 Here, we have established a model in which a small quantity of PVAT is transplanted to the mouse carotid artery to test its effects on neointimal formation. In addition to being the first to assess the local effect of transplanted PVAT on the vasculature, our model is unique in that we transplanted merely 2 to 3 mg of PVAT, which is proportionate to the amount of endogenous PVAT surrounding conduit human arteries (Figure 1 ). Our data using this model suggest that PVAT can enhance the neointimal response to vascular injury through a mechanism involving MCP-1.
The focus in atherosclerosis research has traditionally revolved around the endothelium, the innermost component of the arterial wall. The deeper layers of the arterial wall, including the media and adventitia, have received far less attention yet are clearly important to the disease process. In particular, remodeling of the adventitia, and proliferation of adventitial vasa vasorum, has been detected early in the course of experimental hyperlipidemia, preceding structural and functional changes in the endothelium. 32 Also, the adventitia has been identified as the major site of vascular inflammatory cell accumulation in hyperlipidemic, atherosclerosis-prone apolipoprotein E-deficient mice. 33 These and other studies implicate the vascular adventitia in the pathogenesis of vascular disease (eg, outside-in process of lesion formation). The mechanisms that drive adventitial inflammation and angiogenesis, however, remain to be determined. We demonstrate adventitial inflammation, angiogenesis, and increased neointimal formation in PVAT-transplanted carotid arteries after short-term high-fat feeding and wire injury, suggesting a pathogenic role for PVAT in vascular disease. On the contrary, meticulous removal of all endogenous PVAT enhanced the neointimal response to wire injury in the femoral artery, 19 suggesting that the presence of some amount of PVAT is vasculoprotective in this blood vessel. Moreover, data in the SMPG knockout mouse suggest an atheroprotective effect of PVAT when animals are housed at a reduced temperature, presumably attributable to increased systemic metabolic activity from adaptive thermogenesis. 18 Several studies have examined the impact of transplanted adipose tissue on local vascular biology. In 2 studies, endogenous PVAT was removed and replaced with subcutaneous or visceral fat before performing wire injury of the femoral artery. 19, 21 In these studies, subcutaneous fat transplanted from mice fed a normal diet inhibited neointimal formation after injury, whereas subcutaneous fat transplanted from high-fat, high-sucrose diet-fed mice had no effect. 19 Transplantation of visceral epididymal adipose tissue also diminished neointimal hyperplasia, and this protective effect was lost when the proinflammatory angiopoietin-like protein 2 gene was overexpressed in the transplanted adipose tissue. 21 In a third study, atherosclerosis was quantified after transplantation of visceral or subcutaneous fat to the carotid artery. 20 In this model, epididymal fat transplantation augmented atherosclerosis, whereas subcutaneous fat had minimal effect. 20 In the latter study, the investigators transplanted 60 mg of fat, which is disproportionate to the amount of PVAT that spontaneously forms around conduit arteries. Nevertheless, the augmentation of atherosclerosis observed in that study was clearly a local phenomenon because vessels devoid of transplanted fat were unaffected. Therefore, studies to date have yielded conflicting results, suggesting that the influence of PVAT on vascular pathology is complex and dependent on the particular blood vessel and the experimental model used.
The results obtained in the current study are not strictly comparable with any of the prior publications, because it is the only study in which authentic PVAT was transplanted. PVAT exhibits a distinct phenotype as compared with subcutaneous and epididymal adipose tissues, which must be taken into account when interpreting results from this study in the context of prior publications. To add to the complexity, PVAT in rodents and perhaps humans comprised both brown and white adipose tissue, depending on the anatomic location. 34, 35 The divergent metabolic and inflammatory state of brown versus white adipose tissues may be an important factor in determining how PVAT locally influences vascular pathophysiology in rodent models and in humans.
PVAT differs from both subcutaneous and epididymal adipose tissues, both under basal conditions and after dietary manipulations, which may relate in part to the unique biochemical and molecular properties of perivascular adipocytes. 9, 36 One of the most striking differences between perivascular adipocytes and adipocytes derived from other depots is increased expression of chemokines, especially MCP-1 (10-40-fold increased as compared with subcutaneous and perirenal adipocytes). Our results with PVAT transplanted from MCP-1 −/− mice clearly implicate MCP-1 secretion by PVAT in the vascular response to wire injury. Based on these findings, we expected that neointimal proliferation associated with PVAT transplantation would consist largely of inflammatory cells. Rather, we observed that most of the cells stained positively for α-smooth muscle actin, with relatively few inflammatory cells scattered throughout the neointima. Moreover, although PVAT transplantation triggered pronounced adventitial macrophage infiltration, it was not significantly diminished by ablation of MCP-1 expression in the PVAT. It is possible that polarization of the macrophages was affected by MCP-1 gene deletion in PVAT, based on the limited data with inducible nitric oxide synthase and Ym1 gene expression. Thus, phenotypic changes in macrophages could have indirectly contributed to the reduction in neointimal remodeling observed in the mice transplanted with MCP-1 −/− PVAT. Given the small amount of available tissue, however, we were not able to specifically isolate macrophages from the PVAT tissue, nor were we able to assess expression of other genes related to macrophage polarization. Nevertheless, taken together with the immunostaining data for α-smooth muscle actin, these findings suggest that the effects of MCP-1 expression by PVAT on the vascular response to wire injury are largely independent of monocyte/ macrophage recruitment.
Besides functioning as a chemokine to recruit inflammatory cells, MCP-1 has been demonstrated to elicit diverse effects on the vascular wall, including stimulation of VSMC proliferation and migration. 37, 38 For example, incubation of human VSMC with MCP-1 stimulated an increase in proliferating nuclear cell antigen and cyclin A expression and a 2-fold increase in cell numbers. 38 Mechanistically, MCP-1-induced VSMC proliferation was found to be independent of nuclear factor κβ activation and mediated via phosphatidylinositol 3-kinase activation. 37 Whether MCP-1 expressed in PVAT acts on VSMC to enhance the neointimal response to injury remains to be determined. Also, it is conceivable that the MCP-1 might act on progenitor cells in the PVAT depot or the vascular adventitia, triggering their migration to the neointima and differentiation into a VSMC phenotype. 39 Interestingly, progenitor cells isolated from the aortic adventitia and transferred to the adventitial side of vein grafts implanted into hyperlipidemic mice were demonstrated to migrate to the intima, providing support for such a mechanism. 39 We also observed that PVAT transplantation markedly stimulated adventitial angiogenesis, a finding that may shed light into the mechanisms of adventitial vasa vasorum proliferation after short-term high-fat feeding. 32 In vitro studies demonstrated that perivascular adipocytes, as compared with their subcutaneous and perirenal counterparts, release higher quantities of soluble factors, such as VEGF, that induce proangiogenic responses in endothelial cells. Interestingly, the adventitial angiogenesis was significantly attenuated by transplanting PVAT from MCP-1 −/− mice. A previous report suggested that MCP-1 can induce angiogenesis via upregulation of VEGF gene expression. 40 Further studies will be required to determine whether this mechanism underlies the potent angiogenic effects of PVAT.
In summary, we report here that transplantation of 2 to 3 mg of PVAT to the carotid artery is sufficient to enhance vascular responses to wire injury in HFD-fed, hyperlipidemic mice, leading to accumulation of a VSMC-rich neointima and prominent adventitial inflammation and angiogenesis. The pathogenic effects of PVAT transplantation in this model are mediated in part by expression of MCP-1.
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